See #nanopore sequencing in action & have a go yourself. Don't miss our live demo sessions throughout #AACR23 focusing on rapid variant detection in BRCA1/2, and targeted enrichment of cancer gene panels, using only computational methods. Find out more: bit.ly/3nrdadK

From Oxford to Orlando… If you’re at #AACR23 head over to booth 801 and come speak to a member of the Oxford Nanopore team. We’ve got plenty of talks, workshops and demos in store. Find out more here: nanoporetech.com/events/aacr-an…

Another busy day at the Oxford #Nanopore booth at #AACR23. Make sure you come along tomorrow if you haven’t already and check out our demos and workshops, as well as our Spotlight seminar at 12pm. Find out more here: nanoporetech.com/events/aacr-an…

Single cell sequencing

First Oxford Nanopore tumour/normal analysis workflow accurately calling #somatic SNVs and Indels from WGS and targeted data set of your #cancer samples. #sequencing

Tumour/normal workflow with Oxford Nanopore sequencing. Learn how to accurately detect somatic SNVs, SVs, CNVs and differential methylation in a single data set. What you are missing matters!

At London Calling 2023, Carolin Sauer talked about potential application of #nanopore sequencing for liquid biopsy analysis in children with cancer. New data analysis tools such as those developed by Isidro Cortes-Ciriano's group are key for cancer detection. nanoporetech.com/about-us/news/…

We are hiring. We are opening two positions Università di Firenze funded by the PNRR Project "Tuscany Health Ecosystem"! The topic is the development of a computational tool for the analysis of Oxford Nanopore data in diagnostic applications. contact me for more info! Please share!

NanomonSV coming out in top here for recall and false positive rate for somatic structural variant calling. We’ve implemented it in our Oxford Nanopore EPI2ME somatic variation workflow - more details here: labs.epi2me.io/workflows/wf-s…

What if you could characterise brain tumours in hours, rather than weeks? And in doing so allow neurosurgeons to adjust their surgical strategies on the spot. Here, researchers showed that they were able to do just that by leveraging nanopore technology: bit.ly/46BH8x4

Oxford Oxford Nanopore Technologies is embarking on an exciting journey with Mayo Clinic to advance precision medicine for #cancer and genetic disorders. nanoporetech.com/about-us/news/…

It's time to look at sequencing differently. #ASHG23

"In these times when we have a lot of problems to solve, we can't afford to waste talent." Hear chemistry laureate Michael Levitt speak about the importance of diversity. #NobelPrize

Forget the M3 MacBook Pro, I want this sleek Space Gray DNA sequencer that I saw at the #AppleEvent

Shout out to Dr. Bob Schrieber who proposed the concept of cancer immunoediting and is a pioneer of personalized cancer vaccines. #SITC #sitc2023 #immunotherapies Society for Immunotherapy of Cancer Journal for ImmunoTherapy of Cancer

An incredible keynote by Kaechlab (Sue Kaech) to start off day 2 at the Society for Immunotherapy of Cancer annual meeting on mechanisms of metabolism and opportunities to target metabolism to enhance anti-tumor responses.

You've heard of Data for breakfast, now get ready for Data after dark! Join us for an exclusive in-person informatics update at NCM Houston. Hear the latest updates on basecalling & data analysis. Not got your ticket yet? Get it now: bit.ly/3QYqOjV #nanoporeconf

We are delighted to have Oxford Nanopore as associated partner of the LongTREC Marie Skłodowska-Curie Actions network. Aino Jarvelin is presenting the technology and applications

Many thanks to Cancer Center Amsterdam - Amsterdam UMC for highlighting our recent work using nanopore sequencing and #liquidbiopsy #cfDNA amsterdamumc.org/en/research/in…

If you are attending #AACR this year come and say hello to the Oxford Oxford Nanopore team! We have lots of incredible new things to share with you! #CancerResearch